The first-of-its-kind study published last week in the the 'American Journal of Clinical Nutrition' was conducted by Italian researchers among over 1,000 participants.
Danish pharmaceutical giant Novo Nordisk has said it is set to apply for regulatory approval of its once-a-week insulin drug, Icodec. Results of Phase-3 clinical trial shown 'promising results'.
Developed by US firm Merck & Co, Sitagliptin is used to treat Type 2 diabetes, a condition in which blood sugar goes up because the body does not produce or use insulin normally.
The ICMR has called a virtual meeting of pharma companies and NGOs to discuss the high pricing of cancer, diabetic, thyroid drugs, among others, on 17 August.
The recent resignations of its seniormost judges are among the most pointed institutional protests Pakistan has witnessed since the lawyers’ movement of the late 2000s.
Without a Congress revival, there can be no challenge to the BJP pan-nationally. Modi’s party is growing, and almost entirely at the cost of the Congress.
COMMENTS